Common Stock Options

3 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Common Stock Options

Note 11 – Common Stock Options

Stock Incentive Plan

On June 21, 2016, we amended and restated our 2012 Stock Incentive Plan (the “2012 Plan”), which was originally adopted on March 5, 2012, and terminated on March 5, 2022. As amended, the 2012 Plan provided for the issuance of up to 11,500,000 shares of common stock pursuant to the grant of options or other awards, including stock grants, to employees, officers or directors of, and consultants to, the Company and its subsidiaries. Options granted under the 2012 Plan may either be intended to qualify as incentive stock options under the Internal Revenue Code of 1986, or may be non-qualified options, and are exercisable over periods not exceeding ten years from date of grant.

Common Stock Option Issuances

There were no issuances of common stock options during the three months ended December 31, 2024.

Amortization of Stock-Based Compensation

A total of $0 and $1,153 of stock-based compensation expense was recognized during the three months ended December 31, 2024 and 2023, respectively, as a result of the vesting of common stock options issued in prior periods. As of December 31, 2024 no additional amounts of unamortized expense remains to be amortized over the vesting period.

The following is a summary of information about the stock options outstanding at December 31, 2024.

Shares Underlying Options Outstanding							Shares Underlying Options Exercisable
				Weighted
		Shares		Average	Weighted		Shares		Weighted
Range of		Underlying		Remaining	Average		Underlying		Average
Exercise		Options		Contractual	Exercise		Options		Exercise
Prices		Outstanding		Life	Price		Exercisable		Price
$	.0056-0.13		8,120,000	4.02 years	$	0.052		8,120,000	$	0.052

The following is a summary of activity of outstanding common stock options:

			Weighted
			Average
	Number		Exercise
	of Shares		Price
Balance, September 30, 2024		8,120,000	$	0.052
Options issued		-		-
Options forfeited		-		-
Balance, December 31, 2024		8,120,000	$	0.052
Exercisable, December 31, 2024		8,120,000	$	0.052

As of December 31, 2024, these options in the aggregate had $57,740 of intrinsic value for the outstanding and exercisable options, based on the per share market price of $0.03 of the Company’s common stock as of such date.